Provided by Tiger Trade Technology Pte. Ltd.

Attovia Therapeutics

20.80
+0.59002.92%
Post-market: 20.800.00000.00%19:55 EDT
Volume:362.17K
Turnover:7.43M
Market Cap:895.00M
PE:-13.96
High:21.01
Open:20.21
Low:19.70
Close:20.21
52wk High:24.32
52wk Low:16.15
Shares:43.03M
Float Shares:17.00M
Volume Ratio:1.46
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4900
EPS(LYR):-15.3508
ROE:--
ROA:--
PB:-7.13
PE(LYR):-1.35

Loading ...

Company Profile

Company Name:
Attovia Therapeutics
Exchange:
NASDAQ
Establishment Date:
2022
Employees:
44
Office Location:
1091 Industrial Road,Suite 310,San Carlos,California,United States
Zip Code:
94070
Fax:
- -
Introduction:
Atento S.A., together with its subsidiaries, provides customer relationship management business process outsourcing services and solutions in Brazil, the Americas, Europe, the Middle East, and Africa. It offers a range of front and back-end services, including sales, customer care, technical support, collections, and back office. The company serves clients primarily in the telecommunications, financial services, consumer goods, retail, public administration, healthcare, travel, transportation, logistics, and technology and media sectors. It provides its services and solutions through digital channels, which include SMS, email, chats, social media and apps, and others, as well as through voice. The company was formerly known as Atento Floatco S.A. Atento S.A. was founded in 1999 and is based in Luxembourg.

Directors

Name
Position
James Topper
Chairman of the Board and Director
Tao Fu
Chief Executive Officer and Director and President
Aaron Royston
Director
Angie You
Director
Colin Walsh
Director
John W. Smither
Director
Mitchell Gold
Director

Shareholders

Name
Position
Tao Fu
Chief Executive Officer and Director and President
Steven Chan
Chief Financial Officer
Hubert Chen
Chief Medical Officer
Petter Veiby
Chief Scientific Officer
Zaneta Odrowaz
Chief Business Officer and Secretary and Treasurer